Marchán Juan Carlos Meneu-Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marchán Juan Carlos Meneu-Diaz has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
E Moreno-Gonzalez
4 shared publicationsA. Moreno
3 shared publications- Baltasar Pérez Saborido
Gastroenterology Service, Hematology Service, Pathology Service, Surgery Service, Hospital Río Hortega, Valladolid, Spain
3 shared publications C Jimenez
3 shared publications- Manuel Abradelo
Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications A Moreno Elola-Olaso
2 shared publications
Latest Publications
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S474
6607 POSTER Description of Mutation in CNR1 Gene and VEGF Expression in Esophageal Cancer
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S474
6607 POSTER Description of Mutation in CNR1 Gene and VEGF Expression in Esophageal Cancer
- Open Access
- 28 August 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (9) , 1110-1118
Liver transplantation using uncontrolled non–heart-beating donors under normothermic extracorporeal membrane oxygenation
Because of the organ shortage, non–heart-beating donors have been proposed as a possible source of grafts for orthotopic liver transplantation (OLT). Despite the widespread use of controlled non–heart-beating donors, there are only a few published studies reporting the outcomes with uncontrolled non–heart-beating donors (UNHBDs). A prospective case-control study on adult patients undergoing OLT was designed. We used normothermic extracorporeal membrane oxygenation (NECMO) in all UNHBDs. Matching 2:1 ratio comparison was performed between a study group (UNHBDs) and a brain death donor (BDD) control group. Between January 2006 and March 2008, a total of 60 patients were included: 20 in the UNHBD group and 40 in the control group. The incidence of ischemic cholangiopathy was 5% (n = 1) for the UNHBD group and 0% for the BDD group (P = 0.15). The rate of primary nonfunction was 10% (n = 2) in UNHBD recipients and 2.5% (n = 1) in BDD recipients (P = 0.21), with graft loss in all of them. Three patients were retransplanted in the UNHBD group (15%), 2 of them because of primary nonfunction and 1 because of ischemic cholangiopathy; no patient was retransplanted in the control group (P = 0.012). After a mean follow-up of 330.4 ± 224.9 days, 1-year cumulative patient survival was 85.5% for the UNHBD group and 87.5% for the BDD group (P = 0.768). One-year cumulative graft survival was 80% in the UNHBD group and 87.5% in the BDD group (P = 0.774). In conclusion, UNHBDs under NECMO are a potential source of organs for OLT with encouraging outcomes potentially comparable to those obtained with BDDs.
- 28 August 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (9) , 1110-1118
Open AccessLiver transplantation using uncontrolled non–heart-beating donors under normothermic extracorporeal membrane oxygenation
Because of the organ shortage, non–heart-beating donors have been proposed as a possible source of grafts for orthotopic liver transplantation (OLT). Despite the widespread use of controlled non–heart-beating donors, there are only a few published studies reporting the outcomes with uncontrolled non–heart-beating donors (UNHBDs). A prospective case-control study on adult patients undergoing OLT was designed. We used normothermic extracorporeal membrane oxygenation (NECMO) in all UNHBDs. Matching 2:1 ratio comparison was performed between a study group (UNHBDs) and a brain death donor (BDD) control group. Between January 2006 and March 2008, a total of 60 patients were included: 20 in the UNHBD group and 40 in the control group. The incidence of ischemic cholangiopathy was 5% (n = 1) for the UNHBD group and 0% for the BDD group (P = 0.15). The rate of primary nonfunction was 10% (n = 2) in UNHBD recipients and 2.5% (n = 1) in BDD recipients (P = 0.21), with graft loss in all of them. Three patients were retransplanted in the UNHBD group (15%), 2 of them because of primary nonfunction and 1 because of ischemic cholangiopathy; no patient was retransplanted in the control group (P = 0.012). After a mean follow-up of 330.4 ± 224.9 days, 1-year cumulative patient survival was 85.5% for the UNHBD group and 87.5% for the BDD group (P = 0.768). One-year cumulative graft survival was 80% in the UNHBD group and 87.5% in the BDD group (P = 0.774). In conclusion, UNHBDs under NECMO are a potential source of organs for OLT with encouraging outcomes potentially comparable to those obtained with BDDs.
- 24 December 2008
- Vol. 55, 1699-704
Starting a new program of split liver transplantation after a low learning curve: a reality in centers with large experience in liver surgery and whole liver transplantation.
Split liver transplantation (SLT) is nowadays, considered an adequate surgical solution to expand the grafts from the existing pool of cadaveric donors. A total of 897 liver transplantations were performed between 1986 and 2002; 20 were SLTs (2.3%). A 30% were children. Mean follow up of 15.15 months +/- 13.85. Median age was 42.27 +/- 25.65 yrs. Median recipient weight was 52.29 +/- 20.87 Kg. Mean donor weight was 76.1 +/- 13.11. The majority was "in situ" SLT (65%). There was no primary graft dysfunction. Two patients developed biliary complications (none in situ SLT). Early HAT occurred in 2 patients and delayed HAT in one. Four patients were retransplanted but none were performed because of primary graft dysfunction. Five patients died in the hospital. Fifteen patients (75%) survived the postoperative period and 3 patients died during follow-up. Mean patient survival time was 42 months (95% CI: 31-52). Actuarial patient survival was 93.3%, 84.4%, 84.4% at 6 months, 1 year and 3 years. Mean graft survival was 36 months (95% CI: 25-48). Actuarial graft survival was 87%, 72%, 72% at 6, 12, 36 months. Univariate analysis of risk factors for graft loss showed that the type of splitting technique (p=0.019), and the UNOS (1 and 2a) status of the recipient (p=0.001) were significantly associated with graft loss. In the context of large volume full cadaveric liver transplantation, split liver can provide adequate results (even after a short learning curve) mainly in elective cases and with the in situ technique.
- 24 December 2008
- Vol. 55, 1699-704
Starting a new program of split liver transplantation after a low learning curve: a reality in centers with large experience in liver surgery and whole liver transplantation.
Split liver transplantation (SLT) is nowadays, considered an adequate surgical solution to expand the grafts from the existing pool of cadaveric donors. A total of 897 liver transplantations were performed between 1986 and 2002; 20 were SLTs (2.3%). A 30% were children. Mean follow up of 15.15 months +/- 13.85. Median age was 42.27 +/- 25.65 yrs. Median recipient weight was 52.29 +/- 20.87 Kg. Mean donor weight was 76.1 +/- 13.11. The majority was "in situ" SLT (65%). There was no primary graft dysfunction. Two patients developed biliary complications (none in situ SLT). Early HAT occurred in 2 patients and delayed HAT in one. Four patients were retransplanted but none were performed because of primary graft dysfunction. Five patients died in the hospital. Fifteen patients (75%) survived the postoperative period and 3 patients died during follow-up. Mean patient survival time was 42 months (95% CI: 31-52). Actuarial patient survival was 93.3%, 84.4%, 84.4% at 6 months, 1 year and 3 years. Mean graft survival was 36 months (95% CI: 25-48). Actuarial graft survival was 87%, 72%, 72% at 6, 12, 36 months. Univariate analysis of risk factors for graft loss showed that the type of splitting technique (p=0.019), and the UNOS (1 and 2a) status of the recipient (p=0.001) were significantly associated with graft loss. In the context of large volume full cadaveric liver transplantation, split liver can provide adequate results (even after a short learning curve) mainly in elective cases and with the in situ technique.
- 24 December 2008
- Vol. 55, 1738-41
Transhiatal esophagectomy for squamous cell carcinoma in liver transplant recipients.
- 24 December 2008
- Vol. 55, 1738-41
Transhiatal esophagectomy for squamous cell carcinoma in liver transplant recipients.
- 1 September 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (7) , 2304-2307
Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma: Recurrence Pathway and Prognostic Factors
- 1 September 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (7) , 2304-2307
Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma: Recurrence Pathway and Prognostic Factors
- Open Access
- 1 October 2006
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 98 (10) , 723-739
First Spanish series of intestinal transplantation in adult recipients
Short-bowel transplantation has experienced a substantial growth worldwide following improved results from the late 1990's on, and its coverage by Medicare. According to the International Registry (1985-2005), a total of 1,292 intestinal transplants for 1,210 patients in 65 hospitals across 20 countries have been carried out thus far. to know short-term (6 months) results regarding patient and graft survival from the first Spanish series of intestinal transplants in adult recipients. we present our experience in the assessment of 20 potential candidates to short-bowel transplantation between June 2004 and October 2005. Of these, 10 patients were rejected and 4 were transplanted, which makes up the sample of our study. to this date 5 transplants have been carried out in 4 patients (2 retransplants, 2 desmoid tumors, 1 short bowel syndrome after excision as a result of mesenteric ischemia). Upon study completion and after a mean follow-up of 180 days (range 90-190 days) all recipients are alive, and all grafts but one (75%) are fully operational, with complete digestive autonomy. All patients received induction with alemtuzumab except one, who received thymoglobulin; in all induction was initiated with no steroids. intestinal transplantation represents a therapeutic option that is applicable in our setting and valid for recipients with an indication who have no other feasible alternative to keep their intestinal failure under control.
- 1 October 2006
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 98 (10) , 723-739
Open AccessFirst Spanish series of intestinal transplantation in adult recipients
Short-bowel transplantation has experienced a substantial growth worldwide following improved results from the late 1990's on, and its coverage by Medicare. According to the International Registry (1985-2005), a total of 1,292 intestinal transplants for 1,210 patients in 65 hospitals across 20 countries have been carried out thus far. to know short-term (6 months) results regarding patient and graft survival from the first Spanish series of intestinal transplants in adult recipients. we present our experience in the assessment of 20 potential candidates to short-bowel transplantation between June 2004 and October 2005. Of these, 10 patients were rejected and 4 were transplanted, which makes up the sample of our study. to this date 5 transplants have been carried out in 4 patients (2 retransplants, 2 desmoid tumors, 1 short bowel syndrome after excision as a result of mesenteric ischemia). Upon study completion and after a mean follow-up of 180 days (range 90-190 days) all recipients are alive, and all grafts but one (75%) are fully operational, with complete digestive autonomy. All patients received induction with alemtuzumab except one, who received thymoglobulin; in all induction was initiated with no steroids. intestinal transplantation represents a therapeutic option that is applicable in our setting and valid for recipients with an indication who have no other feasible alternative to keep their intestinal failure under control.
- Open Access
- 1 November 2004
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 139 (11) , 1189-1193
Simultaneous Liver-Kidney Transplantation for Adult Recipients With Irreversible End-Stage Renal Disease
Although refinements in surgical technique and improvement in medical management have resulted in better short-term and long-term patient and allograft outcomes,1 the negative impact of renal insufficiency on survival in patients undergoing liver transplantation has been widely reported,2-4 although some aspects are still controversial.5-7
- 1 November 2004
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 139 (11) , 1189-1193
Open AccessSimultaneous Liver-Kidney Transplantation for Adult Recipients With Irreversible End-Stage Renal Disease
Although refinements in surgical technique and improvement in medical management have resulted in better short-term and long-term patient and allograft outcomes,1 the negative impact of renal insufficiency on survival in patients undergoing liver transplantation has been widely reported,2-4 although some aspects are still controversial.5-7
- 12 March 2004
- Vol. 51 (55) , 103-5
Exceptional bilateral adrenalectomy after secondaries from colorectal cancer.
We report a very uncommon case of bilateral adrenal metastasis treated at our institution. The patient was 65 years old, with a history of low anterior resection for colorectal cancer in 2001. One year later, he was diagnosed with bilateral adrenal metastasis, based on the results of abdominal computed tomography-scan. A bilateral adrenalectomy extended to distal pancreatectomy and splenectomy was performed. Postoperative course was uneventful. He is alive and free of disease 12 months after adrenalectomy. We conclude adrenal metastasis from colorectal cancer should be managed surgically, even if they are bilateral.
- 12 March 2004
- Vol. 51 (55) , 103-5
Exceptional bilateral adrenalectomy after secondaries from colorectal cancer.
We report a very uncommon case of bilateral adrenal metastasis treated at our institution. The patient was 65 years old, with a history of low anterior resection for colorectal cancer in 2001. One year later, he was diagnosed with bilateral adrenal metastasis, based on the results of abdominal computed tomography-scan. A bilateral adrenalectomy extended to distal pancreatectomy and splenectomy was performed. Postoperative course was uneventful. He is alive and free of disease 12 months after adrenalectomy. We conclude adrenal metastasis from colorectal cancer should be managed surgically, even if they are bilateral.
- 31 December 2003
- Vol. 50 (54) , 2143-8
Liver recipients undergoing hepatic transplantation and subsequent retransplantation: a comparison between clinical characteristics.
In order to establish a rational strategy for organ distribution and optimal patient management, we postulate it is mandatory not only to understand the pathophysiology of failing grafts but also to better recognize the baseline clinical characteristics of the recipients shortly before receiving a second liver allograft. Between March 1986 and December 1997, 1061 patients underwent 1087 orthotopic liver transplantation at three Hospitals in Madrid (122 retransplants). Mean follow-up was 36 months (range, 1-90), 40.6% of the recipients were alive and survival at 1, 3 and 5 years was 62%, 53%, and 46%. Almost 50% of the recipients were UNOS 1 before retransplantation. In comparison to p-OLT (15% UNOS 1), it is clearly shown that the retransplants have been performed in the sickest patients with more adverse prognostic indicators (higher AST, bilirubin, creatinine serum levels, higher Child-Pugh score, higher rate of ascites and lower serum levels of albumin and prothrombin activity). Liver retransplantation is acceptable and significant differences in recipients' baseline characteristics suggest an impact on lower survival.
- 31 December 2003
- Vol. 50 (54) , 2143-8
Liver recipients undergoing hepatic transplantation and subsequent retransplantation: a comparison between clinical characteristics.
In order to establish a rational strategy for organ distribution and optimal patient management, we postulate it is mandatory not only to understand the pathophysiology of failing grafts but also to better recognize the baseline clinical characteristics of the recipients shortly before receiving a second liver allograft. Between March 1986 and December 1997, 1061 patients underwent 1087 orthotopic liver transplantation at three Hospitals in Madrid (122 retransplants). Mean follow-up was 36 months (range, 1-90), 40.6% of the recipients were alive and survival at 1, 3 and 5 years was 62%, 53%, and 46%. Almost 50% of the recipients were UNOS 1 before retransplantation. In comparison to p-OLT (15% UNOS 1), it is clearly shown that the retransplants have been performed in the sickest patients with more adverse prognostic indicators (higher AST, bilirubin, creatinine serum levels, higher Child-Pugh score, higher rate of ascites and lower serum levels of albumin and prothrombin activity). Liver retransplantation is acceptable and significant differences in recipients' baseline characteristics suggest an impact on lower survival.
- 30 August 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (5) , 1863-1865
Simultaneous liver-kidney transplant for combined renal and hepatic end-stage disease
- 30 August 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (5) , 1863-1865
Simultaneous liver-kidney transplant for combined renal and hepatic end-stage disease